[Proteus infection of the urine? Look for the stone!].

J. Slors,F. M. Rasker,J. Netelenbos

Abstract:

What problem does this paper attempt to address?

Causal risk and protective factors in rheumatoid arthritis: A genetic update

M Arleevskaya,E Takha,S Petrov,G Kazarian,A Novikov,R Larionova,A Valeeva,E Shuralev,M Mukminov,C Bost,Y Renaudineau

DOI: https://doi.org/10.1016/j.jtauto.2021.100119

2021-09-03

Abstract:The characterization of risk and protective factors in complex diseases such as rheumatoid arthritis (RA) has evolved from epidemiological studies, which test association, to the use of Mendelian randomization approaches, which test direct relationships. Indeed, direct associations with the mucosal origin of RA are retrieved with periodontal disease (Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans predominantly), interstitial lung involvement, tobacco smoking and air pollutants. Next, factors directly associated with an acquired immune response include genetic factors (HLA DRB1, PTPN22), capacity to produce anti-modified protein antibodies (AMPA), and relatives with a history of autoimmune diseases. Finally, factors can be also classified according to their direct capacity to interfere with the IL-6/CRP/sIL-IL6R proinflammatory pathway as risk factor (body fat, cardiometabolic factors, type 2 diabetes, depressive syndrome) or either as protective factors by controlling of sIL-6R levels (higher education level, and intelligence). Although some co-founders have been characterized (e.g. vitamin D, physical activity, cancer) the direct association with sex-discrepancy, pregnancy, and infections among other factors remains to be better explored.
Epidemiology of rheumatoid arthritis: genetic and environmental influences

Aliki I. Venetsanopoulou,Yannis Alamanos,Paraskevi V. Voulgari,Alexandros A. Drosos

DOI: https://doi.org/10.1080/1744666X.2022.2106970

2022-07-31

Expert Review of Clinical Immunology

Abstract:Rheumatoid arthritis (RA) is a chronic systemic disease characterized by articular involvement and extra-articular manifestations. The incidence and prevalence of the disease vary across populations, and there is an ongoing debate on whether a change of RA occurrence over time exists or is due to methodological issues and other biases. Moreover, the disease's onset is related to an interaction of genetic and environmental factors that influence its expression. This review explores the latest knowledge on RA epidemiology and the possible risk factors associated with its presentation to identify potential warning signs that may in the future help disease management. Current epidemiological evidence suggests a significant impact of smoking, sex hormones, and lifestyle status in RA occurrence. However, the association between these variables has not yet been thoroughly studied. Still, their effect must be interpreted as they may present subsequently integral indicators for a more rational approach of the disease.

immunology
Epidemiology and Risk Factors for Rheumatoid Arthritis Development

Aliki I Venetsanopoulou,Yannis Alamanos,Paraskevi V Voulgari,Alexandros A Drosos,Aliki I. Venetsanopoulou,Paraskevi V. Voulgari,Alexandros A. Drosos

DOI: https://doi.org/10.31138/mjr.301223.eaf

2023-12-01

Mediterranean Journal of Rheumatology

Abstract:Rheumatoid arthritis (RA) is a prevalent chronic inflammatory arthritis worldwide, significantly impacting patients and population health. The disease affects women primarily, with a female-to-male ratio of three to one. Its pathogenesis is multifactorial, including genetic and environmental risk factors. Epidemiological studies highlight the link between the environment and genetic susceptibility to RA. The so-called shared epitope is the most significant risk factor that seems to act synergetic with other environmental factors in the disease occurrence. In addition, recent findings suggest a potential role of new substantial environmental factors, such as the observed pollution of the planet's natural resources, on the susceptibility and progression of the disease. This review summarises the most decisive evidence on epidemiology and genetic, environmental, and lifestyle risk factors for RA. It shows that studying genetic and environmental factors in correlation could lead to prevention strategies that may impact the natural history of the disease.
Purification of the high-molecular-weight form of adenosine deaminase from rabbit intestine.

C. Piggott,T. Brady

DOI: https://doi.org/10.1042/bj1190006pb

IF: 3.766

Biochemical Journal

Abstract:
Utilization and evaluation of maternity care by American Indians in Arizona

D. A. Sullivan,R. Beeman

DOI: https://doi.org/10.1007/BF01318931

Journal of Community Health

Abstract:
Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

A. M. Mohamed Thoufic Ali,S. Vino

DOI: https://doi.org/10.1007/s00296-016-3563-7

2016-09-16

Rheumatology International

Abstract:Rheumatoid arthritis (RA) is a chronic, inflammatory, multi-systemic autoimmune disease unremitted by genetic and environmental factors. The factors are crucial but inadequate in the development of disease; however, these factors can be representative of potential therapeutic targets and response to clinical therapy. Insights into the contribution of genetic risk factors are currently in progress with studies querying the genetic variation, their role in gene expression of coding and non-coding genes and other mechanisms of disease. In this review, we describe the significance of genetic markers architecture of RA through genome-wide association studies and meta-analysis studies. Further, it also reveals the mechanism of disease pathogenesis investigated through the mutual findings of functional and genetic studies of individual RA-associated genes, which includes HLA-DRB1, HLA-DQB1, HLA-DPB1, PADI4, PTPN22, TRAF1-C5, STAT4 and C5orf30. However, the genetic background of RA remains to be clearly depicted. Prospective efforts of the post-genomic and functional genomic period can travel toward real possible assessment of the genetic effect on RA. The discovery of novel genes associated with the disease can be appropriate in identifying potential biomarkers, which could assist in early diagnosis and aggressive treatment.

rheumatology
Non-plasma proteins in cerebrospinal fluid.

E. Bock

Abstract:
[Risk factors for the development of rheumatoid arthritis]

A Finckh

2014-03-12

Abstract:The role of genetic factors in the development rheumatoid arthritis (RA) is starting to be better understood. For patients to develop an autoimmunity associated with RA, an interaction between genetic risk factors and environmental risk factors seems to be required. In this paper, we will describe the putative role of a specific genetic risk factor and discuss several environmental risk factors, such as air pollution or specific infections, as well as behavioral factors such as smoking or specific foods. Ultimately, a better understanding of the gene-environment interactions leading to the development of autoimmunity will allow to identify people at high risk of developing RA, and perhaps to initiate preventive measures to avoid the disease of occurring all together.
The effect of aqueous leaching of glucosinolates on the nutritive quality of rapeseed meal.

Y. Rauchberger,S. Mokady,U. Cogan

DOI: https://doi.org/10.1002/JSFA.2740300107

The Journal of the Science of Food and Agriculture

Abstract:Studies were conducted with the aim to upgrade the nutritional quality of high glucosinolate rapeseed meals, via heat treatment and aqueous leaching of the glucosinolates, under various conditions of temperature and pH. Conditions for thermal pretreatment of the seeds were sought which ensured complete inactivation of the enzyme myrosinase, no reduction in available lysine, and minimal losses of soluble protein during subsequent leaching processes. This was achieved by 30 min steaming at 100°C, although kinetic studies showed that complete inactivation of the enzyme took place within 5 min. Leaching experiments were performed with full-fat flakes and with defatted meal. The rate as well as the total amount of leached glucosinolates was higher in defatted meal compared to full-fat flakes. Protein losses were similar with both types of rapeseed raw material and were only slightly affected by changing the pH. Oil losses from full-fat flakes during the leaching process were significant. Raising the leaching temperature from 25 to 50°C increased substantially the rate and the total amount of leached glucosinolates, but resulted in higher losses of protein. Generally, raising the pH of the leaching medium in the range of 4–8, resulted in an increase in the rate as well as in the total amount of leached glucosinolates. Rat feeding tests (PER) of leached meals indicated that raising the leaching temperature from 25 to 50°C lowered the protein quality of the meals. On the other hand, meals leached under the same temperature conditions, in the pH range of 4–8, were not found significantly different in their protein nutritive value. Substantial heat treatment was also found necessary for improving the nutritive quality of low glucosinolate rapeseed.
The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis

Mansour Zamanpoor

DOI: https://doi.org/10.1111/cge.13498

2019-01-28

Clinical Genetics

Abstract:Abstract Rheumatoid arthritis (RA) is a systemic autoimmune disease that causes chronic inflammation of the joints. RA is a heterogeneous disorder caused by an abnormal autoimmune response triggered by the complex interactions of genetics and environmental factors that contribute to RA aetiology. However, its underlying pathogenic mechanisms are yet to be fully understood. In this review, I provide an overview of the pathogenesis, diagnosis and therapeutic insight in the clinical management of RA in light of the recent updates to classification criteria and recent discoveries of genetic loci associated with susceptibility for RA. This article is protected by copyright. All rights reserved.

genetics & heredity
Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis

Javier Courel-Ibáñez,Tomas Vetrovsky,Nora Růžičková,Concepción Marañón,Krzysztof Durkalec-Michalski,Michal Tomcik,Mária Filková

DOI: https://doi.org/10.1007/s00296-023-05507-y

2024-01-06

Rheumatology International

Abstract:There is increasing knowledge in the recognition of individuals at risk for progression to rheumatoid arthritis (RA) before the clinical manifestation of the disease. This prodromal phase preceding the manifestation of RA may represent a "window of opportunity" for preventive interventions that may transform the clinical approach to this disease. However, limited evidence exists in support of effective interventions to delay the onset or even halt the manifestation of RA. Given the multifactorial nature of RA development and disease progression, the latest guidelines for established RA stress the use of integrative interventions and multidisciplinary care strategies, combining pharmacologic treatment with non-pharmacological approaches. Accordingly, individuals at risk of RA could be offered an integrative, multifactorial intervention approach. Current data point toward pharmacological intervention reverting the subclinical inflammation and delay in the disease onset. In addition, targeting life style modifiable factors (smoking cessation, dental health, physical activity, and diet) may presumably improve RA prognosis in individuals at risk, mainly by changes in epigenetics, autoantibodies, cytokines profiles, and microbiome. Nonetheless, the benefits of multidisciplinary interventions to halt the manifestation of RA in at-risk individuals remain unknown. As there is a growing knowledge of possible pharmacological intervention in the preclinical phase, this narrative review aims to provide a comprehensive overview of non-pharmacological treatments in individuals at risk of RA. Considering the mechanisms preceding the clinical manifestation of RA we explored all aspects that would be worth modifying and that would represent an integrative non-pharmacological care for individuals at risk of RA.

rheumatology
At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization

Marina I. Arleevskaya,Andrej A. Novikov,Anna R. Valeeva,Marina O. Korovina,Igor L. Serdiuk,Vladimir A. Popov,Caroline Carlé,Yves Renaudineau

DOI: https://doi.org/10.3390/jcm13102796

IF: 3.9

2024-05-09

Journal of Clinical Medicine

Abstract:Patients with rheumatoid arthritis (RA) are prone to develop infections. Methods: Accordingly, 195 untreated early (e)RA patients and 398 healthy controls were selected from women in Tatarstan's cohort to study infectious history in the anamnesis (four criteria) and in the previous year (16 criteria). Information about annual infections was collected face-to-face from year to year by a qualified rheumatologist/ general practitioner and included the active use of information from medical records. Results: In the anamnesis, tuberculosis, and pneumonia, and in the previous year, respiratory tract infections, skin infections, and herpes simplex virus reactivation incidence were reported to be increased in eRA patients, as well as the event number and duration of acute and chronic tonsillitis. Moreover, more bacterial-suspected upper respiratory infections and urinary tract infections were retrieved in sporadic eRA patients as compared to familial eRA patients. An elevated immunization against CCP prevented respiratory tract infection in those with HSV exacerbation. Finally, associations were retrieved between infection (event number/delay) and RA indices: (i) chronic tonsillitis exacerbations with disease activity and health assessment (HAQ) in familial eRA; (ii) bacterial-suspected upper respiratory infections with the number of swollen and tender joints in sporadic eRA; and (iii) HSV exacerbation with inflammation in eRA patients with negative/low response against CCP. Here, we demonstrate the complex nature of the interplay of RA with specific infections. Conclusions: For the first time, differences in the patterns of annual trivial infections and their links with RA indices were found in cohorts of familial and sporadic cases of the disease. Additionally, for the first time, we identified a remarkable relationship between early RA and exacerbations of chronic tonsillitis, as well as tuberculosis in the patient's history. Altogether, this study supports the existence of a complex interplay between infections and RA at onset driven by familial status and the presence of anti-CCP Ab at elevated levels.

medicine, general & internal
2‐Aminooxazolines, I: Crystal and Molecular Structure of 5‐(1‐Aryl‐4‐piperazino)methylsubstituted Derivatives with Antidepressant Activity

C. Jarry,J. Bosc,J. Ouhabi,A. Carpy

DOI: https://doi.org/10.1002/ardp.19903230306

Archiv der Pharmazie

Abstract:The structure of two 5‐(1‐aryl‐4‐piperazino)methyl‐2‐aminooxazolines were determined by X‐ray crystallography. An amino form is preponderant in a free base whereas an imino form is preponderant in a salt. The molecular conformations were studied by molecular mechanics.
Bugs & us: the role of the gut in autoimmunity

David Luckey,Andres Gomez,Joseph Murray,Bryan White,Veena Taneja

Abstract:Rheumatoid arthritis (RA) is a multifactorial disease and requires interaction between genetic and environmental factors for predisposition. The presence of bacterial DNA of the gut residing commensals in synovium as well as dysbiosis of certain commensal bacteria in faecal samples of RA patients as compared to controls suggest a significant role of the gut flora in pathogenesis of RA. The gut commensals are involved in host immune development and function suggesting they might be critical epigenetic factors modifying autoimmune diseases like RA. This raises the question if gut-derived commensal can be exploited to generate a biomarker profile along with genetic factors to define individuals at risk. Genomic wide association studies have confirmed the HLA (human leukocyte antigen) class II genes as the strongest risk factor for predisposition to RA. HLA-DQ8 and DRB1FNx010401 molecules predispose to develop arthritis while DRB1FNx010402 provides protection. Interaction between host genetic factors like major histocompatibility complex (MHC) and gut microbiota and its impact on the development of RA is difficult to study in humans due to high variability in the genetic factors and diet. Animal models provide a means to study the molecular basis of pathogenesis thereby providing a basis for developing therapeutic strategies. Using transgenic mice expressing RA-associated and resistant HLA genes, we have developed a collagen-induced arthritis (CIA) model that shares similarities with human disease in sex-bias, autoantibody profile and phenotype. Studies in transgenic mice suggest that arthritis-susceptibility may be associated with dysbiosis in the gut microbiome. Studies in animal models underscore the impact of the gut flora in extra-intestinal diseases. Exploring the role of gut microbes will significantly advance our understanding of RA pathogenesis and may further help develop strategies for mucosal modulation of RA.
Challenges in the treatment of Rheumatoid Arthritis

Paola Conigliaro,Paola Triggianese,Erica De Martino,Giulia Lavinia Fonti,Maria Sole Chimenti,Flavia Sunzini,Alessandra Viola,Claudia Canofari,Roberto Perricone

DOI: https://doi.org/10.1016/j.autrev.2019.05.007

IF: 17.39

2019-07-01

Autoimmunity Reviews

Abstract:<p>Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by a heterogeneous clinical response to the different treatments. Some patients are difficult to treat and do not reach the treatment targets as clinical remission or low disease activity. Known negative prognostic factors, such as the presence of auto-antiantibodies and joint erosion, the presence of a genetic profile, comorbidities and extra-articular manifestations, pregnancy or a pregnancy wish may concur to the treatment failure. In this review we aimed at identify difficult to treat RA patients and define the optimal therapeutic and environmental targets. Genetic markers of severity such as HLA-DRB1, TRAF1, PSORS1C1 and microRNA 146a are differently associated with joint damage; other gene polymorphisms seem to be associated with response to biologic disease modifying anti-rheumatic drugs (bDMARDs). The presence of comorbidities and/or extra-articular manifestations may influence the therapeutic choice; overweight and obese patients are less responsive to TNF inhibitors. In this context the patient profiling can improve the clinical outcome. Targeting different pathways, molecules, and cells involved in the pathogenesis of RA may in part justify the lack response of some patients. An overview of the future therapeutic targets, including bDMARDs (inhibitors of IL-6, GM-CSF, matrix metalloproteinases, chemokines) and targeted synthetic DMARDs (filgotinib, ABT-494, pefacitinib, decernotinib), and environmental targets is addressed. Environmental factors, such as diet and cigarette smoke, may influence susceptibility to autoimmune diseases and interfere with inflammatory pathways. Mediterranean diet, low salt intake, cocoa, curcumin, and physical activity seem to show beneficial effects, however studies of dose finding, safety and efficacy in RA need to be performed.</p>

immunology
Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality

Burkhard Möller,Florian Kollert,Anton Sculean,Peter M Villiger

DOI: https://doi.org/10.3389/fimmu.2020.01108

2020-06-03

Abstract:Rheumatoid arthritis (RA) is a systemic immune mediated inflammatory disease of unknown origin, which is predominantly affecting the joints. Antibodies against citrullinated peptides are a rather specific immunological hallmark of this heterogeneous entity. Furthermore, certain sequences of the third hypervariable region of human leukocyte antigen (HLA)-DR class II major histocompatibility (MHC) molecules, the so called "shared epitope" sequences, appear to promote autoantibody positive types of RA. However, MHC-II molecule and other genetic associations with RA could not be linked to immune responses against specific citrullinated peptides, nor do genetic factors fully explain the origin of RA. Consequently, non-genetic factors must play an important role in the complex interaction of endogenous and exogenous disease factors. Tobacco smoking was the first environmental factor that was associated with onset and severity of RA. Notably, smoking is also an established risk factor for oral diseases. Furthermore, smoking is associated with extra-articular RA manifestations such as interstitial lung disease in anatomical proximity to the airway mucosa, but also with subcutaneous rheumatoid nodules. In the mouth, Porphyromonas gingivalis is a periodontal pathogen with unique citrullinating capacity of foreign microbial antigens as well as candidate RA autoantigens. Although the original hypothesis that this single pathogen is causative for RA remained unproven, epidemiological as well as experimental evidence linking periodontitis (PD) with RA is rapidly accumulating. Other periopathogens such as Aggregatibacter actinomycetemcomitans and Prevotella intermedia were also proposed to play a specific immunodominant role in context of RA. However, demonstration of T cell reactivity against citrullinated, MHC-II presented autoantigens from RA synovium coinciding with immunity against Prevotella copri (Pc.), a gut microbe attracted attention to another mucosal site, the intestine. Pc. was accumulated in the feces of clinically healthy subjects with citrulline directed immune responses and was correlated with RA onset. In conclusion, we retrieved more than one line of evidence for mucosal sites and different microbial taxa to be potentially involved in the development of RA. This review gives an overview of infectious agents and mucosal pathologies, and discusses the current evidence for causality between different exogenous or mucosal factors and systemic inflammation in RA.
Electron trapping in very thin thermal silicon dioxides

M. Liang,C. Hu

DOI: https://doi.org/10.1109/IEDM.1981.190097

1981-12-01

Abstract:Constant current stress and C-V techniques have been used to study the electron trapping phenomenon in thermally grown thin SiO2films A mathematical model based on trap filling and trap generation is proposed and the capture cross-sections, trap generation rates, the centroids, and the densities of the pre-existing and generated traps are determined as functions of the current density. The generation of interface states is also characterized.
OA01 Cluster medicine: the role of genetics for identifying shared biological pathways between rheumatoid arthritis and common comorbidities for targeting treatments

Martin Stoves,Mehreen Soomro,Sizheng Steven Zhao,Darren Plant,Anne Barton,John Bowes

DOI: https://doi.org/10.1093/rheumatology/keae163.001

2024-04-01

Rheumatology

Abstract:Abstract Background/Aims Rheumatoid arthritis (RA) is a chronic inflammatory disorder associated with significant pain and disability, as well as increased risk of comorbidities. These comorbidities, such as coronary artery disease, stroke, heart failure and type 2 diabetes, often form predictable clusters highlighting the importance of common disease mechanisms. Identifying these clusters, and the underlying shared mechanisms, is key to the concept of cluster medicine which aims to take a more systemic approach to treating comorbidity. It is hypothesised that inflammatory processes in RA promote the pathogenesis of these comorbid diseases, which typically occur at an earlier stage of life than in the general population. However, few studies have investigated the degree of shared genetic susceptibility implicated across these traits. The present study aimed to identify and characterise pleiotropic loci and shared biological pathways involved in the pathogenesis of RA and cardiometabolic disorders. Methods European-only GWAS summary statistics were collected for RA (seropositive, seronegative, and overall) and seven cardiometabolic traits, including ischemic stroke, any stroke, heart failure, coronary artery disease, hypertension, atrial fibrillation, and type 2 diabetes. Cross-trait linkage disequilibrium score regression was employed to estimate the degree of genetic correlation (rg) between all pairs of traits. Subset-based meta-analysis was performed using the R package ASSET to identify pleiotropic single nucleotide polymorphisms (SNPs). Pleiotropic SNPs were assigned to genes based on positional and eQTL mapping. Prioritised genes were tested for over-representation in functional categories and biological pathways in gene sets obtained from MsigDB and WikiPathways using the hypergeometric test loci. Gene mapping and enrichment analyses were conducted in FUMA. Results RA showed significant positive genetic correlation with all cardiometabolic traits, with the seronegative subtype showing greater correlation than the seropositive subtype. Correlations between RA and cardiometabolic phenotypes ranged from 0.11 - 0.38, the strongest of which was between seronegative RA and heart failure (rg = 0.38, P = 2.6e-07). A total of 67 lead SNPs were identified as potentially pleiotropic. Pleiotropic SNPs were mapped to genes including IL6R, PTPN11, ATXN2, PLCL1 and SOX6. Pathway enrichment analyses revealed that mapped genes were primarily involved in inflammatory signalling pathways, involving interleukins, TNF-α and interferon (gamma and alpha) response. Conclusion This study provides evidence for pleiotropy across RA and cardiometabolic traits, whereby inherited genetic variants predispose to aberrant cytokine signalling, thus conferring risk to multiple diseases where inflammation is a key driver of pathogenesis. Disclosure M. Stoves: None. M. Soomro: None. S. Zhao: None. D. Plant: None. A. Barton: None. J. Bowes: None.

rheumatology
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

Anna-Lena Mueller,Zahra Payandeh,Niloufar Mohammadkhani,Shaden M. H. Mubarak,Alireza Zakeri,Armina Alagheband Bahrami,Aranka Brockmueller,Mehdi Shakibaei

DOI: https://doi.org/10.3390/cells10113017

IF: 6

2021-11-04

Cells

Abstract:Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.

cell biology
False-negative N.B.T. tests due to transient malfunction of neutrophils.

A. Rubinstein,B. Pelet

DOI: https://doi.org/10.1016/S0140-6736(73)90185-2

IF: 202.731

1973-02-17

The Lancet

Abstract:

[Proteus infection of the urine? Look for the stone!].

Causal risk and protective factors in rheumatoid arthritis: A genetic update

Epidemiology of rheumatoid arthritis: genetic and environmental influences

Epidemiology and Risk Factors for Rheumatoid Arthritis Development

Purification of the high-molecular-weight form of adenosine deaminase from rabbit intestine.

Utilization and evaluation of maternity care by American Indians in Arizona

Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Non-plasma proteins in cerebrospinal fluid.

[Risk factors for the development of rheumatoid arthritis]

The effect of aqueous leaching of glucosinolates on the nutritive quality of rapeseed meal.

The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis

Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis

At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization

2‐Aminooxazolines, I: Crystal and Molecular Structure of 5‐(1‐Aryl‐4‐piperazino)methylsubstituted Derivatives with Antidepressant Activity

Bugs & us: the role of the gut in autoimmunity

Challenges in the treatment of Rheumatoid Arthritis

Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality

Electron trapping in very thin thermal silicon dioxides

OA01 Cluster medicine: the role of genetics for identifying shared biological pathways between rheumatoid arthritis and common comorbidities for targeting treatments

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

False-negative N.B.T. tests due to transient malfunction of neutrophils.